These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15016325)

  • 21. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.
    Basu S; Binder RJ; Ramalingam T; Srivastava PK
    Immunity; 2001 Mar; 14(3):303-13. PubMed ID: 11290339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma.
    Bachleitner-Hofmann T; Strohschneider M; Krieger P; Sachet M; Dubsky P; Hayden H; Schoppmann SF; Pfragner R; Gnant M; Friedl J; Stift A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4571-7. PubMed ID: 16954161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
    Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
    J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70.
    Udono H; Yamano T; Kawabata Y; Ueda M; Yui K
    Int Immunol; 2001 Oct; 13(10):1233-42. PubMed ID: 11581168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses.
    Wang XH; Qin Y; Hu MH; Xie Y
    World J Gastroenterol; 2005 Sep; 11(36):5614-20. PubMed ID: 16237753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides.
    Nair S; Wearsch PA; Mitchell DA; Wassenberg JJ; Gilboa E; Nicchitta CV
    J Immunol; 1999 Jun; 162(11):6426-32. PubMed ID: 10352256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling.
    Bendz H; Ruhland SC; Pandya MJ; Hainzl O; Riegelsberger S; Braüchle C; Mayer MP; Buchner J; Issels RD; Noessner E
    J Biol Chem; 2007 Oct; 282(43):31688-702. PubMed ID: 17684010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic induction of antigen-specific CTL by fusions of TLR-stimulated dendritic cells and heat-stressed tumor cells.
    Koido S; Hara E; Homma S; Mitsunaga M; Takahara A; Nagasaki E; Kawahara H; Watanabe M; Toyama Y; Yanagisawa S; Kobayashi S; Yanaga K; Fujise K; Gong J; Tajiri H
    J Immunol; 2007 Oct; 179(7):4874-83. PubMed ID: 17878387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses.
    Nouri-Shirazi M; Banchereau J; Bell D; Burkeholder S; Kraus ET; Davoust J; Palucka KA
    J Immunol; 2000 Oct; 165(7):3797-803. PubMed ID: 11034385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced generation of cytotoxic T lymphocytes by increased cytosolic delivery of MHC class I epitope fused to mouse heat shock protein 70 via polyhistidine conjugation.
    Takemoto S; Nishikawa M; Otsuki T; Yamaoka A; Maeda K; Ota A; Takakura Y
    J Control Release; 2009 Apr; 135(1):11-8. PubMed ID: 19100299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70.
    Xie Y; Bai O; Zhang H; Yuan J; Zong S; Chibbar R; Slattery K; Qureshi M; Wei Y; Deng Y; Xiang J
    J Cell Mol Med; 2010 Nov; 14(11):2655-66. PubMed ID: 19627400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-presentation of NY-ESO-1 cytotoxic T lymphocyte epitope fused to human heat shock cognate protein 70 by dendritic cells.
    Susumu S; Nagata Y; Ito S; Matsuo M; Valmori D; Yui K; Udono H; Kanematsu T
    Cancer Sci; 2008 Jan; 99(1):107-12. PubMed ID: 17991294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting to static endosome is required for efficient cross-presentation of endoplasmic reticulum-resident oxygen-regulated protein 150-peptide complexes.
    Kutomi G; Tamura Y; Okuya K; Yamamoto T; Hirohashi Y; Kamiguchi K; Oura J; Saito K; Torigoe T; Ogawa S; Hirata K; Sato N
    J Immunol; 2009 Nov; 183(9):5861-9. PubMed ID: 19812200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
    Hetttihewa LM
    Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: implications for the clinical use of dendritic cells.
    Schnell S; Young JW; Houghton AN; Sadelain M
    J Immunol; 2000 Feb; 164(3):1243-50. PubMed ID: 10640737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic-tumor fusion cells derived heat shock protein70-peptide complex has enhanced immunogenicity.
    Zhang Y; Zhang Y; Chen J; Liu Y; Luo W
    PLoS One; 2015; 10(5):e0126075. PubMed ID: 25961716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced endoplasmic reticulum entry of tumor antigen is crucial for cross-presentation induced by dendritic cell-targeted vaccination.
    Wang H; Yu X; Guo C; Zuo D; Fisher PB; Subjeck JR; Wang XY
    J Immunol; 2013 Dec; 191(12):6010-21. PubMed ID: 24218449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.